WHO ICTRP trial
Cohort study evaluating efficacy and safety of gemcitabine for advanced or…
JPRN-UMIN000013002 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000013002 |
|---|---|
| Public title | Cohort study evaluating efficacy and safety of gemcitabine for advanced or metastatic breast cancer (YCOG1005) |
| Scientific title | Cohort study evaluating efficacy and safety of gemcitabine for advanced or metastatic breast cancer (YCOG1005) - Cohort study evaluating efficacy and safety of gemcitabine for advanced or metastatic breast cancer (YCOG1005) |
| Primary sponsor | Yokohama City University Medical Center |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Observational |
| Phase | Not selected |
| Countries | Japan |
| Conditions | breast cancer |
| Registration date | Jan 29, 2014 |
| Target size | 100 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: